Baxdela
Take Advantage of Newer Antibiotic Options
Antibiotic-resistant infections and deaths increased by 15% during the pandemic, according to the Infectious ...
OCTOBER 13, 2022
Baxdela for SSSIs Now Available
The oral and IV formulations of Baxdelafor the treatment of adults with acute bacterial skin and skin structure ...
JANUARY 30, 2018
FDA Approves Baxdela for Acute Bacterial Skin and Skin Structure Infections
Delafloxacin is a fluoroquinolone that exhibits activity against both gram-positive and gram-negative pathogens, ...
JUNE 26, 2017
Load more